154 related articles for article (PubMed ID: 21722690)
1. Development of a source-to-outcome model for dietary exposures to insecticide residues: an example using chlorpyrifos.
Hinderliter PM; Price PS; Bartels MJ; Timchalk C; Poet TS
Regul Toxicol Pharmacol; 2011 Oct; 61(1):82-92. PubMed ID: 21722690
[TBL] [Abstract][Full Text] [Related]
2. Application of a source-to-outcome model for the assessment of health impacts from dietary exposures to insecticide residues.
Price PS; Schnelle KD; Cleveland CB; Bartels MJ; Hinderliter PM; Timchalk C; Poet TS
Regul Toxicol Pharmacol; 2011 Oct; 61(1):23-31. PubMed ID: 21651950
[TBL] [Abstract][Full Text] [Related]
3. An age-dependent physiologically based pharmacokinetic/pharmacodynamic model for the organophosphorus insecticide chlorpyrifos in the preweanling rat.
Timchalk C; Kousba AA; Poet TS
Toxicol Sci; 2007 Aug; 98(2):348-65. PubMed ID: 17504771
[TBL] [Abstract][Full Text] [Related]
4. Development of a physiologically based pharmacokinetic and pharmacodynamic model to determine dosimetry and cholinesterase inhibition for a binary mixture of chlorpyrifos and diazinon in the rat.
Timchalk C; Poet TS
Neurotoxicology; 2008 May; 29(3):428-43. PubMed ID: 18394709
[TBL] [Abstract][Full Text] [Related]
5. Repeated dose 28-day oral toxicity study in Wistar rats with a mixture of five pesticides often found as residues in food: alphacypermethrin, bromopropylate, carbendazim, chlorpyrifos and mancozeb.
Jacobsen H; Østergaard G; Lam HR; Poulsen ME; Frandsen H; Ladefoged O; Meyer O
Food Chem Toxicol; 2004 Aug; 42(8):1269-77. PubMed ID: 15207377
[TBL] [Abstract][Full Text] [Related]
6. Use of a probabilistic PBPK/PD model to calculate Data Derived Extrapolation Factors for chlorpyrifos.
Poet TS; Timchalk C; Bartels MJ; Smith JN; McDougal R; Juberg DR; Price PS
Regul Toxicol Pharmacol; 2017 Jun; 86():59-73. PubMed ID: 28238854
[TBL] [Abstract][Full Text] [Related]
7. Age-dependent pharmacokinetic and pharmacodynamic response in preweanling rats following oral exposure to the organophosphorus insecticide chlorpyrifos.
Timchalk C; Poet TS; Kousba AA
Toxicology; 2006 Mar; 220(1):13-25. PubMed ID: 16343727
[TBL] [Abstract][Full Text] [Related]
8. Effect of in vivo nicotine exposure on chlorpyrifos pharmacokinetics and pharmacodynamics in rats.
Lee S; Poet TS; Smith JN; Busby-Hjerpe AL; Timchalk C
Chem Biol Interact; 2010 Mar; 184(3):449-57. PubMed ID: 20097188
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P450-specific human PBPK/PD models for the organophosphorus pesticides: chlorpyrifos and parathion.
Foxenberg RJ; Ellison CA; Knaak JB; Ma C; Olson JR
Toxicology; 2011 Jul; 285(1-2):57-66. PubMed ID: 21514354
[TBL] [Abstract][Full Text] [Related]
10. A human life-stage physiologically based pharmacokinetic and pharmacodynamic model for chlorpyrifos: development and validation.
Smith JN; Hinderliter PM; Timchalk C; Bartels MJ; Poet TS
Regul Toxicol Pharmacol; 2014 Aug; 69(3):580-97. PubMed ID: 24200834
[TBL] [Abstract][Full Text] [Related]
11. A Physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model for the organophosphate insecticide chlorpyrifos in rats and humans.
Timchalk C; Nolan RJ; Mendrala AL; Dittenber DA; Brzak KA; Mattsson JL
Toxicol Sci; 2002 Mar; 66(1):34-53. PubMed ID: 11861971
[TBL] [Abstract][Full Text] [Related]
12. Cholinesterase inhibition in chlorpyrifos workers: Characterization of biomarkers of exposure and response in relation to urinary TCPy.
Garabrant DH; Aylward LL; Berent S; Chen Q; Timchalk C; Burns CJ; Hays SM; Albers JW
J Expo Sci Environ Epidemiol; 2009 Nov; 19(7):634-42. PubMed ID: 18716607
[TBL] [Abstract][Full Text] [Related]
13. Appraisal of risks from nonoccupational exposure to chlorpyrifos.
Cochran RC
Regul Toxicol Pharmacol; 2002 Feb; 35(1):105-21. PubMed ID: 11846640
[TBL] [Abstract][Full Text] [Related]
14. Using physiologically-based pharmacokinetic models to incorporate chemical and non-chemical stressors into cumulative risk assessment: a case study of pesticide exposures.
Wason SC; Smith TJ; Perry MJ; Levy JI
Int J Environ Res Public Health; 2012 May; 9(5):1971-83. PubMed ID: 22754485
[TBL] [Abstract][Full Text] [Related]
15. Bayesian calibration of a physiologically based pharmacokinetic/pharmacodynamic model of carbaryl cholinesterase inhibition.
Nong A; Tan YM; Krolski ME; Wang J; Lunchick C; Conolly RB; Clewell HJ
J Toxicol Environ Health A; 2008; 71(20):1363-81. PubMed ID: 18704829
[TBL] [Abstract][Full Text] [Related]
16. Physiologically based pharmacokinetic/pharmacodynamic model for the organophosphorus pesticide diazinon.
Poet TS; Kousba AA; Dennison SL; Timchalk C
Neurotoxicology; 2004 Dec; 25(6):1013-30. PubMed ID: 15474619
[TBL] [Abstract][Full Text] [Related]
17. Modeled estimates of chlorpyrifos exposure and dose for the Minnesota and Arizona NHEXAS populations.
Buck RJ; Ozkaynak H; Xue J; Zartarian VG; Hammerstrom K
J Expo Anal Environ Epidemiol; 2001; 11(3):253-68. PubMed ID: 11477522
[TBL] [Abstract][Full Text] [Related]
18. Rat brain CYP2B-enzymatic activation of chlorpyrifos to the oxon mediates cholinergic neurotoxicity.
Khokhar JY; Tyndale RF
Toxicol Sci; 2012 Apr; 126(2):325-35. PubMed ID: 22287024
[TBL] [Abstract][Full Text] [Related]
19. A physiologically based pharmacokinetic/pharmacodynamic model for carbofuran in Sprague-Dawley rats using the exposure-related dose estimating model.
Zhang X; Tsang AM; Okino MS; Power FW; Knaak JB; Harrison LS; Dary CC
Toxicol Sci; 2007 Dec; 100(2):345-59. PubMed ID: 17804862
[TBL] [Abstract][Full Text] [Related]
20. Derivation of human Biomonitoring Guidance Values for chlorpyrifos using a physiologically based pharmacokinetic and pharmacodynamic model of cholinesterase inhibition.
Arnold SM; Morriss A; Velovitch J; Juberg D; Burns CJ; Bartels M; Aggarwal M; Poet T; Hays S; Price P
Regul Toxicol Pharmacol; 2015 Mar; 71(2):235-43. PubMed ID: 25543108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
